Clinical Trial Update: Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating prophylactic intrathecal thiotepa for SVZ-positive or meninges-risk glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Glioblastoma (GBM) | Phase 2 | Status: RECRUITING